Rigel Pharmaceuticals (RIGL)

Add to Watchlists
Create an Alert
3.71 +0.10  +2.77% NASDAQ Dec 13, 16:59 Delayed 2m USD

Rigel Pharmaceuticals Price to Book Value:

9.676 for Dec. 13, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Rigel Pharmaceuticals Price to Book Value Chart

Export Data
Save Image
Print Image

Rigel Pharmaceuticals Historical Price to Book Value Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 13, 2017 9.676
Dec. 12, 2017 9.415
Dec. 11, 2017 9.598
Dec. 8, 2017 10.38
Dec. 7, 2017 10.12
Dec. 6, 2017 9.728
Dec. 5, 2017 9.728
Dec. 4, 2017 10.30
Dec. 1, 2017 10.67
Nov. 30, 2017 10.85
Nov. 29, 2017 10.54
Nov. 28, 2017 10.98
Nov. 27, 2017 11.22
Nov. 24, 2017 11.08
Nov. 22, 2017 11.08
Nov. 21, 2017 10.28
Nov. 20, 2017 10.02
Nov. 17, 2017 9.963
Nov. 16, 2017 10.15
Nov. 15, 2017 9.859
Nov. 14, 2017 9.754
Nov. 13, 2017 9.702
Nov. 10, 2017 10.04
Nov. 9, 2017 9.754
Nov. 8, 2017 9.989
Nov. 7, 2017 10.02
   
Nov. 6, 2017 9.885
Nov. 3, 2017 10.12
Nov. 2, 2017 10.15
Nov. 1, 2017 9.728
Oct. 31, 2017 9.695
Oct. 30, 2017 9.824
Oct. 27, 2017 9.876
Oct. 26, 2017 9.824
Oct. 25, 2017 9.721
Oct. 24, 2017 9.772
Oct. 23, 2017 9.721
Oct. 20, 2017 10.06
Oct. 19, 2017 10.26
Oct. 18, 2017 10.39
Oct. 17, 2017 10.94
Oct. 16, 2017 10.01
Oct. 13, 2017 9.746
Oct. 12, 2017 9.928
Oct. 11, 2017 10.16
Oct. 10, 2017 10.08
Oct. 9, 2017 8.726
Oct. 6, 2017 8.593
Oct. 5, 2017 8.637
Oct. 4, 2017 8.017
Oct. 3, 2017 7.154

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

RIGL Price to Book Value Benchmarks

Benchmarks
Endocyte 2.212
Catabasis Pharmaceuticals 2.595
CytomX Therapeutics 18.95

RIGL Price to Book Value Range, Past 5 Years

Minimum 0.9197 Dec 18 2013
Maximum 11.22 Nov 27 2017
Average 2.887

RIGL Price to Book Value Excel Add-In Codes

  • Metric Code: price_to_book_value
  • Latest data point: =YCP("RIGL", "price_to_book_value")
  • Last 5 data points: =YCS("RIGL", "price_to_book_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.